NICE public health guidance
Issued: July 2012
PH38

Preventing type 2 diabetes: risk identification and interventions for individuals at high risk

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ph38

9 References

Ali MK, Echouffo-Tcheugui JB, Williamson DF (2012) How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program? Health Affairs 31 (1): 67–75

The American College of Endocrinology and the American Association of Clinical Endocrinologists (2008) Diagnosis and management of pre-diabetes in the continuum of hyperglycaemia – when do the risks of diabetes begin? A consensus statement. Endocrine Practice 14 (7): 933–46 

Bombelli M, Facchetti R, Sega R et al. (2011) Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage [online]

Chamnan P, Simmons R, Forouhi N et al. (2011) Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the European prospective investigation of cancer – Norfolk cohort: Implications for preventive strategies. Diabetes Care 34: 950–6

Danaei G, Finucane MM, Lu Y et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378: 31–40

The DECODE Study Group (2001) Glucose tolerance and cardiovascular mortality comparison of fasting and 2-hour diagnostic criteria. Archives of Internal Medicine161: 397–405

The DECODE Study Group (2002) Age, body mass index and glucose tolerance in 11 European population-based surveys. Diabetic Medicine 19: 558–65

Department of Health (2006) Health survey England 2004: The health of minority ethnic groups. London: Department of Health

Department of Health (2010) Healthy lives, healthy people: consultation on the funding and commissioning routes for public health. London: Department of Health

Department of Health (2011a) Start active, stay active. A report on physical activity for health from the four home countries' chief medical officers [online]

Department of Health (2011b) National diet and nutrition survey headline results from years 1 and 2 (combined) of the rolling programme (2008/09 – 2009/10) [online]

Department of Health (2011c) Healthy lives, healthy people: update and way forward. Norwich: The Stationery Office

Department of Health (2012) Healthy lives, healthy people: Improving outcomes and supporting transparency. London: Department of Health

Diabetes Prevention Program Research Group (2002) The diabetes prevention program (DPP). Description of lifestyle intervention. Diabetes Care 25: 2165–71

Diabetes Prevention Program Research Group (2012) Long-term safety, tolerability and weight loss associated with metformin in the diabetes prevention program (DPP) outcomes study. Diabetes Care 35: 731–7

Diabetes UK (2012) Diabetes in the UK 2012: Key statistics on diabetes [online]

Eborall H, Stone M, Aujla N et al. (2012) Influences on the uptake of diabetes screening: a qualitative study in primary care. British Journal of General Practice 62 (596): e204–11 (8)

Food Standards Agency (2007) Low income diet and nutrition survey [online]

Gillies CL, Abrams KR, Lambert PC et al. (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. British Medical Journal 334: 299–308

Gray LJ, Taub NA, Khunti K et al. (2010) The Leicester risk assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabetic Medicine 27 (8): 887–95

Gray LJ, Davies MJ, Hiles S et al. (2012) Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting [online] Diabetologia 55: 959–66

Griffin SJ, Little PS, Hales CN et al. (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metabolism Research and Reviews 16: 164–71

The Healthcare Quality Improvement Partnership (2011) National diabetes audit mortality analysis 2007–08 [online]

Hex N, Bartlett C, Wright D et al. (2012) Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabetic Medicine 29: 855–62

International Expert Committee (2009) International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 32: 1327–34

John WG, Hillson R, Alberti G (2012) Use of haemoglobin A1c (HbA1c) in the diagnosis of diabetes mellitus. The implementation of World Health Organization (WHO) guidance [online]

Lindström J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26: 725-31

Lindström J, Peltonen M, Eriksson JG et al. (2008) Determinants for the effectiveness of lifestyle intervention in the Finnish diabetes prevention study. Diabetes Care 31: 857-62

Mostafa SA, Khunti K, Srinivasan BT et al. (2010) The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Research and Clinical Practice 90: 100–8

NHS Health Check Programme (2009) Putting prevention first NHS health check: vascular risk assessment and management best practice guidance. London: Department of Health

The NHS Information Centre for Health and Social Care (2011a) Prescribing for diabetes in England: 2005/6 to 2010/11 [online]

The NHS Information Centre for Health and Social Care (2011b) National diabetes audit mortality analysis: Key findings on mortality rates for people diabetes in England – report for the audit period 2007–2008. Leeds: Health and Social Care Information Centre

The NHS Information Centre for Health and Social Care (2012) Statistics on obesity, physical activity and diet: England 2011 [online]

Paulweber B, Valensi P, Lindström J et al. (2010) A European evidence-based guideline for the prevention of type 2 diabetes. Hormone and Metabolic Research 42: (Suppl. 1) S3–S36

Pan XR, Li GW, Hu YH et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 20 (4): 537–44

Ramachandran A, Snehalatha C, Mary S et al. (2006) The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49: 289–97

Tuomilehto J, Lindström J, Eriksson JG et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 344: 1343–50

Webb DR, Gray LJ, Khunti K et al. (2011) Contrasting cardiovascular risk profiles and prescribed cardio-protective therapies in newly-diagnosed type 2 diabetes identified through screening and standard practice. Diabetes Research and Clinical Practice 91 (3): 280–85

World Health Organization (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies: WHO expert consultation. Lancet 363: 157–63

World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation [online]

World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus [online]

Yorkshire and Humber Public Health Observatory (2010) APHO diabetes prevalence model for England [online]

Zhuo X, Zhang P, Gregg EW et al. (2012a) A nationwide community-based lifestyle program could delay or prevent type 2 diabetes cases and save $5.7 billion in 25 years. Health Affairs 31 (1) 50–60

Zhuo X, Zhang P, Selvin E et al. (2012b) Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: A cost-effectiveness perspective. American Journal of Preventive Medicine 42 (4): 374–81